Mode
Text Size
Log in / Sign up

Nebulised Chinese herbal medicine as adjunctive therapy improves clinical effective rate in pediatric pneumoniaChinese Herbal Medicine Boosts Pneumonia Treatment in Children

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that nebulised Chinese herbal medicine as an adjunct shows a significant improvement in clinical effective rate (OR 3.24).

This meta-analysis synthesized evidence from randomized controlled trials involving 1,764 pediatric patients with pneumonia to evaluate nebulised Chinese herbal medicine as an adjunctive therapy alongside conventional Western treatments.

The primary outcome measured was the total clinical effective rate. The analysis reported a significant improvement in this rate when Chinese herbal medicine was added to standard care, yielding an odds ratio of 3.24 (95% CI: 2.24, 4.68).

While the meta-analysis suggests a statistically significant improvement in clinical effectiveness, specific safety data including adverse events, serious adverse events, and tolerability were not reported. The results are limited by this lack of safety information and the absence of follow-up data.

Clinical application is currently constrained by the lack of detailed safety profiles for the herbal intervention. While the efficacy data suggests a potential benefit as an adjunct therapy, clinicians should exercise caution due to the incomplete reporting of side effects and long-term outcomes.

How this fits prior evidence

This finding addresses a gap in management strategies for pediatric pneumonia, which is characterized by high mortality rates in certain regions (up to 61% for ventilated patients in low- and middle-income countries). While rapid diagnostic panels have been shown to improve antibiotic adjustments, this meta-analysis provides evidence regarding the efficacy of an adjunctive herbal therapy. However, it does not provide information on safety or long-term outcomes.

A new meta-analysis suggests that adding nebulised Chinese herbal medicine to standard treatment may help children with pneumonia recover better. The analysis combined results from several randomized controlled trials involving 1,764 paediatric patients. It found that children who received the herbal medicine plus conventional therapy were more likely to show improvement than those on conventional therapy alone. The odds of a good clinical outcome were more than three times higher with the combination treatment.

However, the study did not report on side effects or safety issues. The researchers evaluated both efficacy and safety, but specific details about adverse events were not provided in the available summary. This means we cannot be sure about the safety of this approach.

This is a meta-analysis, which is a type of study that combines results from multiple smaller studies. While it can provide stronger evidence, it is only as good as the studies it includes. The quality of the individual trials was not described in this summary.

For parents and doctors, this finding is promising but not yet practice-changing. More research is needed to confirm the benefits and to understand the safety profile before this can be recommended as a standard addition to pneumonia treatment in children.

What this means for you:
Adding Chinese herbal medicine to standard care may improve pneumonia recovery in children, but safety data are lacking.

Common questions

What is a meta-analysis?

A meta-analysis is a study that combines results from several smaller studies on the same topic. It can give a more reliable overall answer, but it depends on the quality of the individual studies included.

How many children were in this analysis?

The analysis included 1,764 paediatric patients with pneumonia from several randomized controlled trials.

What does 'odds ratio = 3.24' mean?

It means that children who received the herbal medicine plus standard care were about 3.24 times more likely to have a good clinical outcome compared to those on standard care alone.

Are there any safety concerns?

The study did not report on adverse events or side effects. So we do not know if the herbal medicine caused any harm. More safety data are needed.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
ObjectiveThis study aimed to systematically evaluate the clinical efficacy and safety of nebulised Chinese herbal medicine as an adjunctive therapy for paediatric pneumonia.MethodsA comprehensive search was conducted in the PubMed, Cochrane Library, Web of Science, Embase, China National Knowledge Infrastructure, Wanfang, VIP and Chinese Biomedical Literature electronic databases between inception and 1 November 2025. Randomised controlled trials (RCTs) investigating nebulised Chinese herbal medicine as an adjunctive treatment for paediatric pneumonia were included. Two reviewers independently performed literature selection and data extraction and assessed the methodological quality using the Cochrane risk-of-bias tool. Meta-analysis was performed using Stata 17.0 software, and publication bias was assessed using RevMan 5.4.ResultsSeventeen RCTs involving 1,764 patients were included. The meta-analysis showed that, compared with conventional Western therapy alone, the combination with nebulised Chinese herbal medicine significantly improved the total clinical effective rate [odds ratio = 3.24, 95% CI: (2.24, 4.68), p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.